ArticleTranslational oncology2021

Antitumor efficacy of XPO1 inhibitor Selinexor in KRAS-mutant lung adenocarcinoma patient-derived xenografts.

Joshua C Rosen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.